Long-term care providers who prescribe controlled substances via telehealth may soon be subject to a tiered federal registration system.

The states want the courts to prohibit telehealth prescriptions of the pill and to limit its use to the first seven weeks of pregnancy.

The new notice of proposed rulemaking adheres to calls from Congress and industry for the agency to create a special telemedicine registration system. Its three-tiered approach could cost telehealth companies over $40,

Physicians would have to register with the Drug Enforcement Administration (DEA) for telehealth prescribing of certain controlled substances under a proposed rule issued Wednesday by the agency. "DEA's goal is to provide telehealth access for needed medications while ensuring patient safety and preventing the diversion of medications into the illicit drug market,

A new analysis finds nearly half of the compounded GLP-1 websites didn’t include information on adverse effects, warnings, contraindications.

The Donald Trump-appointed federal judge in Texas who unilaterally ordered the FDA to revoke approval of a widely used abortion drug has now allowed Idaho, Kansas and Missouri to move forward with their own attempts to limit access to the drug.

“Basically, the farther the patients resided from an abortion facility, the more they were depending on the pills being mailed to them,” co-lead researcher Dr. Emily Godfrey, an OB/GYN and family doctor with the University of Washington, said in a news release.

After nearly a decade of machine learning innovations, the FDA has issued its first draft guidance on the use of AI in drug development.

The U.S. Drug Enforcement Administration is announcing three new rules to make permanent some temporary telemedicine flexibilities established

Personalized Health Rx™ (PHRx), a new direct-to-consumer telehealth platform under the parent brand Persona 3.0 and sister company to Persona™ Nutrition, opened its digital doors today with a mission to redefine personalized whole-body health.

An increased public interest and support for medication abortion following the federal Supreme Court ruling, particularly among marginalized groups, suggests a shift towards more accessible and autonomous models of abortion care.